Piramal Group is a global business conglomerate with interests in Pharma, Financial Services, Information Management, Glass Packaging and Real Estate. With offices in 30 countries and brand presence in over 100 markets, the Piramal Group has a global team of over 10,000 people from 21 diverse nationalities.

Since 1984, the Piramal Group has battled complex challenges to stay ahead of the curve. From one of the longest trade union strikes to fluctuating political stands, we have consistently attained organic and inorganic growth, thanks to strong global partnerships and strategic investments in core businesses. Today, the Piramal Group is valued at USD 9.5 billion, with more than 60% of the revenue generated from international markets. Our deal with Abbott in 2010, yielded a business evaluation of USD 3.72 billion – a staggering ~9x sale and ~30x EBITDA.

We believe in India’s economic potential and strive to transform the socio-economic ecosystems for a better tomorrow. Our philanthropic arm, Piramal Foundation runs innovative programmes across the healthcare, education, and water. Our initiatives such as Piramal Sarvajal and Swasthya are case studies at the Harvard Business School.